P3 Health Partners Inc. Class A Common Stock (PIII)
Stock · NASDAQ · Health Care
$4.19as of 10/16/2026
Price chart
Active signals
PIII Signal Track Record
How signals performed across all stocks →What PIII's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.
| Signal | Times | Median 20-session return | Higher after 20 sessions | Last signal |
|---|---|---|---|---|
| Bollinger Band Breakdown | 19 | -12.3% | 42% | October 6, 2026 |
| Bollinger Band Breakout | 20 | -17.4% | 30% | August 7, 2026 |
| Volume Spike | 20 | -20.8% | 25% | September 11, 2026 |
| 200-Day Moving Average TouchActive now | 5 | -19.4% | 20% | October 2, 2025 |
| Any 20-session window (baseline) | -8.0% | 35% |
Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.
About PIII
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company was founded in 2020 and is based in Henderson, Nevada.
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- Employees
- 320
- Website
- ir.p3hp.org/
Fundamentals
- 1-day range
- $4.1$4.32
- Market cap
- $78.90M
- P/E (trailing)
- —
- P/E (forward)
- -20.43
- EPS (trailing)
- $-30.32
- Dividend yield
- —
- Beta
- 1.83
- Avg. volume
- 33.0K
How P3 Health Partners Inc. Class A Common Stock Makes Money
Where the revenue actually goes — FY2024 annual results
Source: 10-K filed Mar 26, 2026 · via SEC EDGAR / Finnhub
Forecasts
2 analyst ratings
P3 Health Partners Inc. Class A Common Stock Competitors
Chosen by industry and closest market cap.
- PIIIP3 Health Partners Inc. Class A Common Stock$4.14▲ 0.00%Market cap $78.90MP/E —$1.52$16.89
- NAKANakamoto Inc. Common Stock$7.13▼ 11.87%Market cap $86.14MP/E —$3.33$42
- ALPSALPS Group Inc Ordinary Share$0.34▲ 0.29%Market cap $69.06MP/E —$0.2293$12.01
- DCGODocGo Inc. Common Stock$0.272▼ 3.55%Market cap $61.74MP/E —$0.2711$1.65
- EUDAEUDA Health Holdings Limited Ordinary Shares$15.4▼ 0.58%Market cap $48.78MP/E —$5.26$86
- CCMConcord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares)$3.63▼ 2.16%Market cap $21.53MP/E —$2.79$6.96
- BMGLBasel Medical Group Ltd Ordinary Shares$3.95▲ 1.02%Market cap $8.92MP/E —$2.56$21.72
| Symbol | Market cap | P/E ratio | Price | 1D | 52-week range |
|---|---|---|---|---|---|
| PIII P3 Health Partners Inc. Class A Common Stock | $78.90M | — | $4.14 | ▲ 0.00% | $1.52$16.89 |
| NAKA Nakamoto Inc. Common Stock | $86.14M | — | $7.13 | ▼ 11.87% | $3.33$42 |
| ALPS ALPS Group Inc Ordinary Share | $69.06M | — | $0.34 | ▲ 0.29% | $0.2293$12.01 |
| DCGO DocGo Inc. Common Stock | $61.74M | — | $0.272 | ▼ 3.55% | $0.2711$1.65 |
| EUDA EUDA Health Holdings Limited Ordinary Shares | $48.78M | — | $15.4 | ▼ 0.58% | $5.26$86 |
| CCM Concord Medical Services Holdings Limited American Depositary Shares (Each represents thirty (30) Class A ordinary shares) | $21.53M | — | $3.63 | ▼ 2.16% | $2.79$6.96 |
| BMGL Basel Medical Group Ltd Ordinary Shares | $8.92M | — | $3.95 | ▲ 1.02% | $2.56$21.72 |
P/E shows — for peers not currently carrying a live signal of their own.
Latest news
Insider Activity
Insider Actions →- Hudson Vegas Investment SPV, LLC · August 13, 2026 · Conversion100.0K
- Hudson Vegas Investment SPV, LLC · August 13, 2026 · J100.0K
- Hudson Vegas Investment SPV, LLC · August 10, 2026 · Sale29.9K @ $16.86
- Hudson Vegas Investment SPV, LLC · August 10, 2026 · Sale19.1K @ $16.05
- Hudson Vegas Investment SPV, LLC · August 10, 2026 · Sale1.0K @ $13.38
- STRAUS DANIEL E · June 10, 2026 · Conversion50.0K
- STRAUS DANIEL E · June 10, 2026 · J50.0K
- Pedersen Leif Elliott · May 8, 2026 · Grant30.0K @ $3.55
Institutional Ownership
March 31, 2026
- Total shares held
- 209.7K
- Total value held
- $599.6K
- Institutional holders
- 13
- Unknown70.6K
- Unknown25.9K
- Unknown20.3K
- Unknown19.8K
- Unknown18.0K
- Unknown15.1K
- Unknown13.4K
- Unknown10.9K
- Unknown10.7K
- Unknown3.1K
See the full, filterable feed with live charts on the MarketWall dashboard.
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 13, 2026
PIII appoints new Chief Clinical Officer
P3 Health Partners announced the appointment of a new Chief Clinical Officer. The executive will oversee clinical operations and strategy for the company. This addition brings additional expertise as the firm pursues its growth plans. The stock is currently trading with a low RSI and near its recent support level.
PIII appoints new Chief Clinical Officer. P3 Health Partners announced the appointment of a new Chief Clinical Officer. The executive will oversee clinical operations and strategy for the company. This addition brings additional expertise as the firm pursues its growth plans. The stock is currently trading with a low RSI and near its recent support level.